© 2025 CSRXP- All Rights Reserved
![](https://www.csrxp.org/wp-content/uploads/2024/04/pills-and-money-business-medical-background-1600xauto@2x.jpg)
The Playbook
![](https://www.csrxp.org/wp-content/uploads/2024/01/3x10.png)
Big Pharma’s business-as-usual playbook relies on egregious pricing practices and rhetoric designed to set and keep drug prices high.
Egregious Practices Driving High Drug Prices
![](https://www.csrxp.org/wp-content/uploads/2024/04/GettyImages-1207560572-scaled-1.jpg)
Out-of-Control Drug Prices
Brand name drug companies are responsible for setting the price of the prescription drugs in their portfolios.
![](https://www.csrxp.org/wp-content/uploads/2024/04/GettyImages-1207560572-scaled-1.jpg)
Patent Abuse
Big Pharma has a long history of price-gouging American patients through tactics designed to game the U.S. patent system and block competition from more affordable alternatives — enabling Big Pharma to maintain monopolies over their biggest money-makers.
Agendas Designed to Keep Drug Prices High
![](https://www.csrxp.org/wp-content/uploads/2024/04/GettyImages-1207560572-scaled-1.jpg)
Innovation Rhetoric
For far too long Big Pharma has used the false excuse that research and development (R&D) costs justify out-of-control prescription drug prices and that solutions to lower prices threaten innovation into new breakthroughs.
![](https://www.csrxp.org/wp-content/uploads/2024/04/GettyImages-1207560572-scaled-1.jpg)
Blame Game
Big Pharma spends millions of dollars each year in an attempt to shift blame for high prescription drug prices onto others in the supply chain.